Key Segments:
By Product Type
-
Reagents & Kits
-
Instruments/Analyzers
-
Consumables & Accessories
-
Software
-
Services
By Radioisotope
-
Iodine-125
-
Cobalt-60
-
Indium-111
-
Tritium
-
Other Radioisotopes
By Application
-
Endocrinology
-
Oncology
-
Toxicology
-
Drug Testing & Pharmacokinetics
-
Clinical Diagnostics
By End User
-
Hospitals
-
Clinical Laboratories
-
Research & Academic Institutes
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated with 36% revenue share in 2025, attributed to advanced diagnostic infrastructure, high RIA adoption, and strong healthcare expenditure.
Ans: Reagents & Kits led the Radioimmunoassay Market, owing to their essential role, reproducibility, cost-effectiveness, and wide application in diagnostics and research.
Ans: Growth is driven by rising prevalence of endocrine disorders, cancers, chronic diseases, and increasing adoption of automated, precise RIA systems.
Ans: The market was valued at USD 1.20 billion in 2025, supported by growing clinical and research laboratory adoption of RIA systems.
Ans: The market is projected to grow at a CAGR of 4.89% from 2026–2033, driven by rising demand for sensitive diagnostics globally.